Rchr
J-GLOBAL ID：202101015628574872
Update date: Jun. 21, 2024
Fujisawa Masayoshi
フジサワ マサヨシ | Fujisawa Masayoshi
Affiliation and department：
Research field (1)：
Human pathology
Research keywords (4)：
blood vessel invasion
, immunohistochemistry
, cancer microenvironment
, breast cancer
Research theme for competitive and other funds (1)：
- 2023 - 2026 AI病理診断に向けた、組織切片の厚さの簡易計測法の開発と標準化技術の確立
Papers (40)：
-
Tianyi Wang, Tong Gao, Masayoshi Fujisawa, Toshiaki Ohara, Masakiyo Sakaguchi, Teizo Yoshimura, Akihiro Matsukawa. SPRED2 Is a Novel Regulator of Autophagy in Hepatocellular Carcinoma Cells and Normal Hepatocytes. International journal of molecular sciences. 2024. 25. 11
-
Hnin-Wint-Wint Swe, Masayoshi Fujisawa, Toshiaki Ohara, Yu Komatsubara, Teizo Yoshimura, Tadahiko Shien, Akihiro Matsukawa. The specific shapes of capillaries are associated with worse prognosis in patients with invasive breast cancer. Pathology international. 2024
-
Tong Gao, Xu Yang, Masayoshi Fujisawa, Toshiaki Ohara, Tianyi Wang, Nahoko Tomonobu, Masakiyo Sakaguchi, Teizo Yoshimura, Akihiro Matsukawa. SPRED2: A Novel Regulator of Epithelial-Mesenchymal Transition and Stemness in Hepatocellular Carcinoma Cells. International journal of molecular sciences. 2023. 24. 5
-
Yuze Wang, Toshiaki Ohara, Yuehua Chen, Yusuke Hamada, Chunning Li, Masayoshi Fujisawa, Teizo Yoshimura, Akihiro Matsukawa. Highly Metastatic Subpopulation of TNBC Cells Has Limited Iron Metabolism and Is a Target of Iron Chelators. Cancers. 2023. 15. 2. 468
-
Chunning Li, Teizo Yoshimura, Miao Tian, Yuze Wang, Takamasa Kondo, Ken-Ichi Yamamoto, Masayoshi Fujisawa, Toshiaki Ohara, Masakiyo Sakaguchi, Akihiro Matsukawa. Exosomal Wnt7a from a low metastatic subclone promotes lung metastasis of a highly metastatic subclone in the murine 4t1 breast cancer. Breast cancer research : BCR. 2022. 24. 1. 60-60
ｍore...
MISC (76)：
-
大原 利章, 陳 悦華, 王 宇沢, 濱田 祐輔, 菊地 覚次, 野間 和広, 田澤 大, 藤澤 真義, 藤原 俊義, 松川 昭博. 鉄キレート効果を持つHIF-PH阻害薬は抗腫瘍免疫応答を向上させる(HIF-PH inhibitors with iron chelating ability enhance the tumor immune response). 日本癌学会総会記事. 2023. 82回. 248-248
-
王 天偉, 高 桐, 藤澤 真義, 大原 利章, 吉村 禎造, 松川 昭博. HCC細胞のオートファジーにおけるSpred2の機能及びmTORC1活性化との関係(Role of Spred2 in autophagy in HCC cells and its relation to mTORC1 activation). 日本病理学会会誌. 2023. 112. 1. 238-238
-
王 宇沢, 大原 利章, チン・ユエファ, 浜田 祐輔, 李 春寧, 藤澤 真義, 松川 昭博. TNBCにおける転移能の獲得と鉄代謝の変動(Changes in iron metabolism associated with the acquisition of metastatic potential in TNBC cells). 日本病理学会会誌. 2023. 112. 1. 240-240
-
Tian Miao, 吉村 禎造, 李 春寧, 大原 利章, 藤澤 真義, 松川 昭博. 腫瘍環境のSpred2欠損は乳がんの増殖と転移を抑制する(Spred2 deficiency in the tumor microenvironment inhibits the progression of breast cancer in mice.). 日本病理学会会誌. 2023. 112. 1. 304-304
-
高 桐, 田 ミョウ, 藤澤 真義, 大原 利章, 王 天偉, 李 春寧, 王 宇沢, トウン・ティンダ・ニン, 吉村 禎造, 松川 昭博. SPRED2は食道がん細胞のマクロファージを、エクソソームのIL6/STAT3を介して、M2表現形に分化させる(SPRED2 polarizes macrophages into M2 phenotype via exosomal IL-6/STAT3 axis in esophageal carcinoma). 日本病理学会会誌. 2023. 112. 1. 354-354
ｍore...
Books (1)：
-
リンパ組織
文光堂 2023 ISBN:9784830604911
Lectures and oral presentations (6)：
-
鉄キレート効果を持つHIF-PH阻害薬は抗腫瘍免疫応答を向上させる(HIF-PH inhibitors with iron chelating ability enhance the tumor immune response)
(日本癌学会総会記事 2023)
-
The role of Spred2 in lung adenocarcinoma
(2022)
-
Double immunostaining for tumor vessel identification and its application in breast cancer prognosis
(2022)
-
Interclonal Cooperation by Exosomal Wnt7a Promotes Lung Metastasis of the 4T1 Breast Cancer cells
(2022)
-
Pseudo-hypoxia by iron chelators consists anti-cancer effect and CD8+ T-cell activation
(2022)
ｍore...
Professional career (1)：
Return to Previous Page
